Women who previously had endometrial cancer and used vaginal estrogen therapy did not have higher risk for cancer recurrence than those who did not use vaginal hormone therapy, according to findings ...

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

Younger adult endometrial cancer survivors with short-term exposure to vaginal estrogen therapy (ET) do not have an elevated risk for endometrial cancer recurrence, according to a study published ...